Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.
Shimizu R, Muto T, Aoyama K, Choi K, Takeuchi M, Koide S, Hasegawa N, Isshiki Y, Togasaki E, Kawajiri-Manako C, Nagao Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Iseki T, Starczynowski DT, Iwama A, Yokote K, Nakaseko C. Shimizu R, et al. Among authors: sakai s. Leuk Res. 2016 Nov;50:85-94. doi: 10.1016/j.leukres.2016.09.018. Epub 2016 Sep 26. Leuk Res. 2016. PMID: 27697661 Free PMC article.
Potential utility of serum soluble LR11 as a diagnostic biomarker for intravascular large B-cell lymphoma.
Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Higashi M, Fujikawa K, Matsue K, Yokote K, Tamaru J, Bujo H, Nakaseko C. Kawaguchi T, et al. Among authors: sakai s. Leuk Lymphoma. 2014 Oct;55(10):2391-4. doi: 10.3109/10428194.2014.880430. Epub 2014 Mar 7. Leuk Lymphoma. 2014. PMID: 24401112 No abstract available.
Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.
Tsukamoto S, Takeuchi M, Kawaguchi T, Togasaki E, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Nishii K, Jiang M, Yokote K, Bujo H, Nakaseko C. Tsukamoto S, et al. Among authors: sakai s. Exp Mol Med. 2014 Apr 4;46(4):e89. doi: 10.1038/emm.2013.161. Exp Mol Med. 2014. PMID: 24699135 Free PMC article.
Acute myeloid leukemia concurrent with spinal epidural extramedullary myeloid sarcoma accompanied by a high CD25 expression and the FLT3-ITD mutation.
Isshiki Y, Ohwada C, Togasaki E, Shimizu R, Hasegawa N, Yamazaki A, Sugita Y, Kawaguchi T, Tsukamoto S, Sakai S, Takeda Y, Takeuchi M, Sakaida E, Shimizu N, Ota S, Yokote K, Iseki T, Nakaseko C. Isshiki Y, et al. Among authors: sakai s. Intern Med. 2014;53(11):1159-64. doi: 10.2169/internalmedicine.53.1137. Epub 2014 Jun 1. Intern Med. 2014. PMID: 24881741 Free article.
Long-term complete remission by infusion of ex vivo-expanded donor-derived CD4(+) lymphocytes for treating an early relapse of Hodgkin lymphoma after cord blood transplantation.
Muto T, Ohwada C, Yamazaki A, Sugita Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Shimizu N, Morio T, Nakaseko C. Muto T, et al. Among authors: sakai s. Leuk Lymphoma. 2016;57(1):230-2. doi: 10.3109/10428194.2015.1041390. Epub 2015 Jun 18. Leuk Lymphoma. 2016. PMID: 25962436 No abstract available.
[Severe stomatitis and ileocecal perforation developed after all-trans retinoic acid monotherapy in an HLA-B51-positive patient with acute promyelocytic leukemia].
Kimura K, Takeuchi M, Hasegawa N, Togasaki E, Shimizu R, Kawajiri C, Muto T, Tsukamoto S, Takeda Y, Ohwada C, Sakaida E, Sakai S, Mimura N, Ota S, Iseki T, Nakaseko C. Kimura K, et al. Among authors: sakai s. Rinsho Ketsueki. 2016 Jun;57(6):765-70. doi: 10.11406/rinketsu.57.765. Rinsho Ketsueki. 2016. PMID: 27384858 Review. Japanese.
Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
Tsukamoto S, Takeuchi M, Kawajiri C, Tanaka S, Nagao Y, Sugita Y, Yamazaki A, Kawaguchi T, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C. Tsukamoto S, et al. Among authors: sakai s. Int J Hematol. 2012 Feb;95(2):204-8. doi: 10.1007/s12185-011-0982-9. Epub 2011 Dec 9. Int J Hematol. 2012. PMID: 22160836
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.
Kawajiri C, Tanaka H, Hashimoto S, Takeda Y, Sakai S, Takagi T, Takeuchi M, Ohwada C, Sakaida E, Shimizu N, Nakaseko C. Kawajiri C, et al. Among authors: sakai s. Int J Hematol. 2014 Apr;99(4):513-8. doi: 10.1007/s12185-014-1531-0. Epub 2014 Feb 15. Int J Hematol. 2014. PMID: 24532437
2,662 results